| Type | Title | Author(s) | Year | Views |
| Discovery and Optimization of 2,4-Diaminoquinazoline Derivatives As a New Class of Potent Dengue Virus InhibitorsJournal:Journal of Medicinal Chemistry Publisher:American Chemical Society. The Journal's web site is located at http://pubs.acs.org/jmc | Chao, B; Tong, XK; Tang, W; Li, DW; He, PL; Garcia, JM; Zeng, LM; Gao, AH; Yang, L; Li, J; Nan, FJ; Jacobs, M; Altmeyer, RM; Zuo, JP; Hu, YH | 2012 | 105 |
| |
| Ezrin interacts with the SARS coronavirus spike protein and restrains infection at the entry stage | Millet, JKG; Kien, FS; Cheung, CY; Siu, YL; CHAN, WL; Li, HY; LEUNG, HL; Jaume, MDA; Bruzzone, R; Peiris, JSM; Altmeyer, RM; Nal-Rogier, BTM | 2012 | 50 |
| |
| Efficient assembly and secretion of recombinant subviral particles of the four dengue serotypes using native prM and E proteinsPublisher:Public Library of Science. The Journal's web site is located at http://www.plosone.org/home.action | Wang, PG; Kudelko, M; Lo, J; Yu Lam Siu, L; Tsz Hin Kwok, K; Sachse, M; Nicholls, JM; Bruzzone, R; Altmeyer, RM; Nal, B | 2009 | 230 |
| |
| H5 pseudotyped lentiviral particles: a new tool for sero-diagnosis of influenza H5N1 infectionProceedings/Conference:Meeting of the Pasteur Asia Network on Emerging Respiratory Diseases, 2007 Publisher:Pasteur Research Centre, the University of Hong Kong. | Garcia, J; Nefkens, I; Lagarde, NJC; Chu, SL; Buchy, P; Altmeyer, RM; Peiris, JSM | 2007 | 110 |
| |
| INFLUENZA H5 PSEUDOTYPED LENTIVIRUSES AND USES THEREOF | Altmeyer, RM; Garcia, J; Peiris, JSM; Buchy, P; Peiris, Malik | 2007 | 231 |
| |
| FcgammaRII-mediated SARS-CoV entry in human B cell linesProceedings/Conference:16th European Congress of Immunology - ECI (FRANCE) | Jaume, MDA; Kien, FS; Kam, YW; Corby, P; Li, PH; Chu, SL; Tse, KS; CHEUNG, YC; Peiris, JSM; Daeron, M; Nal-Rogier, BTM; Altmeyer, RM | 2006 | 137 |
| |
| High throughput screening technological platform: application to drug discovery, sero-diagnosis and cellular biology researchProceedings/Conference:Scientific Conference of the Institut Pasteur International Network 2006 | Garcia, J; Nefkens, I; Choi, PS; Lagarde, NJC; Tang, D; Zuo, JP; Nan, F; Li, J; Vanhoutte, PMGR; Nal-Rogier, BTM; Bruzzone, R; Peiris, JSM; Altmeyer, RM | 2006 | 140 |
| |
| Development of High Throughput Screening platform. Application to drug discovery and Sero-diagnosis.Proceedings/Conference:Journees departementales de Virologie de l’Institut Pasteur, Hanoi. | Garcia, J; Nefkens, I; Choi, PS; Tang, D; Zuo, JP; Nan, F; Li, J; Nal-Rogier, BTM; Peiris, JSM; Altmeyer, RM | 2006 | 135 |
| |
| FCGAMMARII-MEDIATED SARS-COV ENTRY IN HUMAN B CELL LINESProceedings/Conference:Scientific Conference of the Board of Directors of the International Network of Institut Pasteur (RIIP) (VIETNAM) | Jaume, MDA; Kien, FS; Kam, YW; Li, PH; Cheung, YC; Peiris, JSM; Daeron, M; Nal-Rogier, BTM; Altmeyer, RM | 2006 | 123 |
| |
| Immunization with trimeric S glycoprotein protects from SARS-CoV challenge despite the presence of in vitro facilitating antibodiesProceedings/Conference:Xth International Nidovirus Symposium,
Toward Control of SARS and Other Nidovirus Diseases | Kam, YW; Kien, FS; Roberts, A; Cheung, CY; Lamirande, E W; Vogel, L; Chu, SL; Chan, CM; Tse, KS; Subarao, K; Peiris, JSM; Nal-Rogier, BTM; Altmeyer, RM | 2005 | 134 |
| |
| Immunization with trimeric S glycoprotein protects from SARS-CoV challenge despite the presence of in vitro facilitating antibodiesProceedings/Conference:Joint Meeting of the 3 Divisions of the International Union of Microbiological Societies 2005 - XIII International Congress of Virology | Kien, FS; Kam, YW; Roberts, A; Cheung, CY; Lamirande, E W; Vogel, L; Chu, SL; Chan, CM; Tse, KS; Subbarao, K; Peiris, JSM; Nal-Rogier, BTM; Altmeyer, RM | 2005 | 136 |
| |
| Biogenesis and subcellular localization of the SARS coronavirus surface proteinsJournal:The F A S E B Journal Publisher:Federation of American Societies for Experimental Biology. | Nal-Rogier, BTM; Chan, CM; Siu, YL; Chu, SL; Altmeyer, RM | 2004 | 170 |
| |
